Max J Rabinowitz, MD is a hematology and oncology internal medicine in Anchorage, AK with 25 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Max J Rabinowitz, MD NPI is 1295770972. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE
Graduation Year:1999
The provider's business location address is:
2925 DEBARR RD
SUITE 300
ANCHORAGE, AK
ZIP 99508-983
Phone: (907) 279-3155
Fax: (907) 279-3154
The NPI 1295770972 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, dexamethasone sodium phosphate, 1mg (HCPCS:J1100)
- Infusion of chemotherapy into a vein up to 1 hour (HCPCS:96413)
- Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour (HCPCS:96367)
- Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour (HCPCS:96365)
- CT scan of abdomen and pelvis with contrast (HCPCS:74177)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Administration of influenza virus vaccine (HCPCS:G0008)
The enumeration date for this NPI number is 6/18/2006 and was last updated on 11/22/2021.